10x Insights
Loading account…
Companies / Materials / USANA HEALTH SCIENCES INC
USNA

USANA HEALTH SCIENCES INC

MaterialsChemicals
Ticker USNASALT LAKE CITY, UTFiscal year ends JanuaryBook value per share $28.54Diluted shares 18.4M

USANA Health Sciences, Inc. (NYSE: USNA) develops and manufactures high-quality nutritional supplements, functional foods, and personal care products distributed worldwide through multiple channels. The company operates at www.usana.com and serves approximately 387,000 active customers in its core nutritional business… From the company’s description.

Fiscal year 2026 · ends 01-03Changes are against fiscal 2024The amber dot is the latest twelve months, to 2026-07-04
Sales & profitability
$925.26M
+8.3% year over year
Last 12 mo $913.36M
4.05%
−3.7 percentage points
Last 12 mo -0.12%
$11.48M
−72.7% year over year
Last 12 mo $-29.25M
2.28%
−5.6 percentage points
Last 12 mo -4.21%
Cash & financing
$22.35M
−63.4% year over year
Last 12 mo $27.73M
$8.53M
−83.3% year over year
Last 12 mo $15.93M
0.03
Was 0.04× a year earlier
Last 12 mo 0.00
18.6M
−3.1% year over year
Last 12 mo 18.4M

Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.

What USANA HEALTH SCIENCES INC does

In the company’s own words

USANA Health Sciences, Inc. (NYSE: USNA) develops and manufactures high-quality nutritional supplements, functional foods, and personal care products distributed worldwide through multiple channels. The company operates at www.usana.com and serves approximately 387,000 active customers in its core nutritional business as of fiscal year 2025, with total net sales of $925 million.

The company organizes its business into two primary reportable segments: Core nutritional, which represents the majority of operations and distributes products through direct selling via independent Brand Partners and Preferred Customers, and Hiya direct-to-consumer, acquired in December 2024, which operates a subscription-based model for children's health products. USANA also maintains operations through Rise Bar Wellness and Oola Global, acquired in 2022, which expand the company's presence in retail, online marketplaces, and personal development sectors.

USANA operates in 25 geographic markets worldwide, with Mainland China representing the largest single market at approximately 41.3 percent of net sales. The company maintains manufacturing and quality control facilities in Salt Lake City, Utah, and Beijing and Tianjin, China, producing approximately 56 percent of products in-house while contracting with third-party suppliers for the remainder. The company's product portfolio includes the USANA Nutritionals Optimizers line, Essentials and CellSentials foundational supplements, foods including meal replacement shakes and snack bars, and the Celavive skincare system featuring proprietary InCelligence Technology.

Founded in 1992, USANA has evolved from a direct selling nutritional supplement company into an omni-channel health and wellness platform encompassing direct selling, direct-to-consumer subscriptions, third-party marketplaces including Amazon, and retail distribution. The company invests significantly in research and development, expending $10.7 million in fiscal 2025 on product innovation and scientific advancement. International operations represent approximately 75.7 percent of consolidated net sales, making currency fluctuations and geopolitical conditions material factors in financial performance. The company maintains a public listing on the New York Stock Exchange and operates as a U.S.-based multinational corporation subject to SEC regulations.

Company details
Sector
Materials
Industry
Chemicals
Headquarters
SALT LAKE CITY, UT
Fiscal year end
January
CIK
896264
SIC
2833

Financial performance, year by year

Fiscal 2011–2026 · USD
$-151.10M$214.45M$580.00M$945.55M$1.31B2011201220132015201620172018201920212022202320242026Last 12 moLast 12 monthsLast 12 months

The full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.

Ownership

Who owns USANA HEALTH SCIENCES INC — and what changed

Funds as of 2026Q2 · superinvestors as of 2026-06-30

169
funds hold it
0 of 35
superinvestors hold it
$71.24M
held by funds, at market
19.4%
of shares held by funds

Largest fund holders · USANA HEALTH SCIENCES INC’s weight in each

VANGUARD TOTAL STOCK MARKET INDEX FUND
VTI · VANGUARD INDEX FUNDS
0.00%of fund net assets
iShares Russell 2000 ETF
IWM · iShares Trust
0.01%of fund net assets
U.S. SMALL CAP VALUE PORTFOLIO
DFSVX · DFA INVESTMENT DIMENSIONS GROUP INC
0.02%of fund net assets
Schwab Fundamental U.S. Small Company ETF
FNDA · SCHWAB STRATEGIC TRUST
0.03%of fund net assets
Avantis U.S. Small Cap Value ETF
AVUV · American Century ETF Trust
0.01%of fund net assets

Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.

Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.

Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.

Connected research

Put this business in context.

Compare this company with peers, find it in your funds and follow its financial history with your connected AI:

  • “How do USANA HEALTH SCIENCES INC and its peers compare on margins and cash generation over ten years?”
  • “Where did five years of USANA HEALTH SCIENCES INC's earnings go — cash, debt, buybacks, reinvestment?”
  • “What changed in USANA HEALTH SCIENCES INC's last four quarterly filings that the numbers alone won't show?”
See how it works →All research tools with a subscription. Use your own AI account.